Literature DB >> 19895750

Seek and destroy: the ubiquitin----proteasome system in cardiac disease.

Jessica E Rodríguez, Jonathan C Schisler, Cam Patterson, Monte S Willis.   

Abstract

The ubiquitin-proteasome system (UPS) is a major proteolytic system that regulates the degradation of intracellular proteins in the heart. The UPS regulates the turnover of misfolded and damaged proteins, in addition to numerous cellular processes, by affecting the stability of short-lived proteins such as transcription factors and cell signaling pathways. The UPS is tightly regulated by the specificity of ubiquitin ligases that recognize specific substrates and direct the addition of ubiquitin, targeting the substrates for degradation by the 26S proteasome. An increasing number of cardiac ubiquitin ligases have been identified, and the number of substrates each one is known to recognize also has increased, expanding their roles. Although mainly cardioprotective roles have been attributed to ubiquitin ligases, new studies have identified exceptions to this rule. This review discusses the mechanisms of cardiac ubiquitin ligases and identifies their role in common cardiac diseases including cardiac hypertrophy, cardiac atrophy, ischemic heart disease, and diabetic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895750     DOI: 10.1007/s11906-009-0069-7

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  65 in total

1.  Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism.

Authors:  K Avela; M Lipsanen-Nyman; N Idänheimo; E Seemanová; S Rosengren; T P Mäkelä; J Perheentupa; A D Chapelle; A E Lehesjoki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

2.  Insulin resistance in adult cardiomyocytes undergoing dedifferentiation: role of GLUT4 expression and translocation.

Authors:  Nathalie Rosenblatt-Velin; René Lerch; Irène Papageorgiou; Christophe Montessuit
Journal:  FASEB J       Date:  2004-03-19       Impact factor: 5.191

3.  Atrophic remodeling of the transplanted rat heart.

Authors:  Saumya Sharma; Jun Ying; Peter Razeghi; Stanislaw Stepkowski; Heinrich Taegtmeyer
Journal:  Cardiology       Date:  2006-01-02       Impact factor: 1.869

4.  Alteration of 20S proteasome-subtypes and proteasome activator PA28 in skeletal muscle of rat after induction of diabetes mellitus.

Authors:  Simone Merforth; Lothar Kuehn; Antonia Osmers; Burkhardt Dahlmann
Journal:  Int J Biochem Cell Biol       Date:  2003-05       Impact factor: 5.085

5.  MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium.

Authors:  S M Kolodziejczyk; L Wang; K Balazsi; Y DeRepentigny; R Kothary; L A Megeney
Journal:  Curr Biol       Date:  1999-10-21       Impact factor: 10.834

Review 6.  Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation.

Authors:  Chanan Rubin; Gal Gur; Yosef Yarden
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

7.  The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control.

Authors:  Raffaele Marfella; Clara Di Filippo; Michele Portoghese; Mario Siniscalchi; Simone Martis; Franca Ferraraccio; Salvatore Guastafierro; Gianfranco Nicoletti; Michelangela Barbieri; Antonino Coppola; Francesco Rossi; Giuseppe Paolisso; Michele D'Amico
Journal:  Cardiovasc Pathol       Date:  2009-01-14       Impact factor: 2.185

8.  Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart.

Authors:  Peter Razeghi; Kedryn K Baskin; Saumya Sharma; Martin E Young; Stanislaw Stepkowski; M Faadiel Essop; Heinrich Taegtmeyer
Journal:  Biochem Biophys Res Commun       Date:  2006-02-08       Impact factor: 3.575

9.  Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.

Authors:  Hui-Hua Li; Monte S Willis; Pamela Lockyer; Nathaniel Miller; Holly McDonough; David J Glass; Cam Patterson
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

10.  Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.

Authors:  Christian C Witt; Stephanie H Witt; Stefanie Lerche; Dietmar Labeit; Walter Back; Siegfried Labeit
Journal:  EMBO J       Date:  2007-12-20       Impact factor: 11.598

View more
  12 in total

Review 1.  Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.

Authors:  Monte S Willis; W H Davin Townley-Tilson; Eunice Y Kang; Jonathon W Homeister; Cam Patterson
Journal:  Circ Res       Date:  2010-02-19       Impact factor: 17.367

2.  Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination.

Authors:  Lucia Cilenti; Meenakshi P Balakrishnan; Xiao-Liang Wang; Camilla Ambivero; Martin Sterlicchi; Federica del Monte; Xin L Ma; Antonis S Zervos
Journal:  J Mol Cell Cardiol       Date:  2010-12-30       Impact factor: 5.000

Review 3.  Regulation of AMPK by the ubiquitin proteasome system.

Authors:  Makhosazane Zungu; Jonathan C Schisler; M Faadiel Essop; Chris McCudden; Cam Patterson; Monte S Willis
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 4.  Tearin' up my heart: proteolysis in the cardiac sarcomere.

Authors:  Andrea L Portbury; Monte S Willis; Cam Patterson
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

5.  NF-κB inhibition protects against tumor-induced cardiac atrophy in vivo.

Authors:  Ashley Wysong; Marion Couch; Scott Shadfar; Luge Li; Lugi Li; Jessica E Rodriguez; Scott Asher; Xiaoying Yin; Mitchell Gore; Al Baldwin; Cam Patterson; Monte S Willis
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  Cardiac systolic dysfunction in doxorubicin-challenged rats is associated with upregulation of MuRF2 and MuRF3 E3 ligases.

Authors:  Marcia Gracindo da Silva; Elisabete Mattos; Juliana Camacho-Pereira; Tatiana Domitrovic; Antonio Galina; Mauro W Costa; Eleonora Kurtenbach
Journal:  Exp Clin Cardiol       Date:  2012-09

7.  HSC70 is a chaperone for wild-type and mutant cardiac myosin binding protein C.

Authors:  Amelia A Glazier; Neha Hafeez; Dattatreya Mellacheruvu; Venkatesha Basrur; Alexey I Nesvizhskii; Lap Man Lee; Hao Shao; Vi Tang; Jaime M Yob; Jason E Gestwicki; Adam S Helms; Sharlene M Day
Journal:  JCI Insight       Date:  2018-06-07

Review 8.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

Review 9.  Myofibroblast-mediated mechanisms of pathological remodelling of the heart.

Authors:  Karl T Weber; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling
Journal:  Nat Rev Cardiol       Date:  2012-12-04       Impact factor: 32.419

10.  Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling.

Authors:  Kristine M Wadosky; Jessica E Rodríguez; Rebecca L Hite; Jin-na Min; Bethany L Walton; Monte S Willis
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-01-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.